Wall Street Unplugged
Episode: 441August 25, 2016

How to Turn $10,000 into $260,000!

05-02-dividendsWelcome to another episode of Wall Street Unplugged!My guest this week is longtime friend, Marc Lichtenfeld, Chief Income Strategist at the Oxford Club.Marc joins me in talks about perpetual dividend raisers and the absolute fortune investors can make by compounding dividends over long periods. He also shares one of his secrets to buying some of the best high-yielding companies at dirt cheap prices.[app_audio src=”http://traffic.libsyn.com/sainvestorradio/WSU20EP20444.mp3″]Marc then breaks down the biotech sector, an industry he’s covered for years. He talks about one specific area that holds huge promise to discovering cures for cancer, Alzheimer’s and Parkinson’s disease.Also, he shares with us his favorite small-cap biotech name to buy right now.Don’t miss out on this week’s educational segment covering some unique technologies investors need to be aware of. Discussed is a sector already having a tremendous affect on patients, significantly extending the lives of the unfortunate and elderly.As always, thank you for tuning in and good investing!

Links & Resources

  • Stay updated with Marc Lichtenfeld here on his site OxfordClubRadio.com
  • Discover some of Marc’s most recent podcasts on Itunes here
  • Mentioned interview with former DEA agent Robert Mazur
  • Mentioned interview with Frank Abagnale Jr.
  • Marc’s book, Get Rich with Dividends

Stocks Mentioned

  • Chipotle (CMG)
  • 3M (MMM)
  • Hewlett Packard (HPQ)
  • International Business Machines (IBM)
  • Gap (GPS)
  • Darden Restaurants (DRI)
  • Biogen Inc. (BIIB)
  • Amgen Inc. (AMGN)
  • Intel Corporation (INTC)
  • Bio-tech ETF (IBB)
  • GW Pharmaceuticals (GWPH)
  • Foundation Medicine (FMI)
  • Illumina Inc. (ILMN)
  • Pfizer (PFE)
  • Bristol-Myers Squibb (BMY)
  • Prana Biotechnology (PRAN)
  • Corbus Pharmaceuticals (CRBP)
  • Pluristem Therapeutics (PSTI)
  • Brainstorm Cell Therapeutics (BCLI)
  • BioTime (BTX)

Curzio Research publishes market commentary for informational and educational purposes. The opinions expressed and market conditions when the content is published may change. It is not personalized investment advice or an offer to buy or sell securities. Investing involves risk, including possible loss of principal. Do your own research and consult a qualified investment professional before making investment decisions.

Terms of Use | Legal | Privacy Policy

Have a question for Frank and Daniel,
submit it here: askcurzio.com

Follow Frank's Wall Street Unplugged podcast

“I follow you. I’ve gotten amazing ideas for my shows from you.”

Jim CramerMad Money
More Wall Street Unplugged

The cooler PCE isn’t the win you might think

The PCE came in cooler than expected—but there's a catch. Plus, what inflation means for the upcoming earnings season… Trump's meeting of AI leaders… Anthropic's S-1 is a joke… And not all upgrades and downgrades are equal.

Political headwinds can’t derail the AI trade

Forget politics: The AI power story is stronger than ever. Plus, breaking down the market volatility… What the PMI means for inflation… A diesel export ban? … BofA's year-end targets… And McDonald's (MCD) bleak Investor Day.

The market is facing the perfect storm

The perfect storm to push stocks lower. Plus, how Warsh can help ease market fears… Why hyperscalers need to slow AI spending… JB Hunt (JBHT) just sounded the alarm on energy prices… And why did the Clarity Act fail?